

Teladoc (TDOC) closed at $5.73 in the latest trading session, marking a +1.06% move from the prior day.

Counterpoint Mutual Funds LLC increased its position in shares of Teladoc Health, Inc. (NYSE: TDOC) by 1,017.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,650,165 shares of the health services provider's stock after purchasing an additional 1,502,488 shares during

NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2026 results on Wednesday, October 28, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.

In the closing of the recent trading day, Teladoc (TDOC) stood at $6, denoting a +1.35% move from the preceding trading day.

Teladoc Health (NYSE: TDOC - Get Free Report) and Schrodinger (NASDAQ: SDGR - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk. Risk and Volatility Teladoc Health has a beta of

TDOC expands Solo with AI tools that streamline virtual assessments and clinical documentation, targeting simpler workflows for hospitals.

The latest trading day saw Teladoc (TDOC) settling at $5.56, representing a -3.64% change from its previous close.

Seeking Alpha welcomed 38 new analysts in September 2026. This article showcases their top picks and investment strategies. Highlighted companies include Qualcomm, Teladoc, and NewLake Capital Partners, as well as the ETF TDAQ, each with a detailed investment thesis. We invite you all to engage with our new contributing analysts, explore their diverse investment theses, and consider following up on the highlighted stock ideas.